Log In
Print this Print this

Jakafi, Jakavi, ruxolitinib (INCB18424)

Also known as: INC424, INCB018424

  Manage Alerts
Collapse Summary General Information
Company Incyte Corp.
DescriptionOral Janus kinase-1 (JAK-1) and JAK-2 inhibitor
Molecular Target Janus kinase-1 (JAK-1) ; Janus kinase-2 (JAK-2)
Mechanism of ActionJanus kinase-2 (JAK-2) inhibitor; Janus kinase-1 (JAK-1) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today